Investors in the Bay Area's booming biotech market are extending a recent string of high-profile sales and leases with CBRE Investment Management's acquisition of a majority stake in two sizable San Francisco life sciences portfolios.
Investors in the Bay Area's booming biotech market are extending a recent string of high-profile sales and leases with CBRE Investment Management's acquisition of a majority stake in two sizable San Francisco life sciences portfolios.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
409 Illinois St, San Francisco, CA
Real Estate